HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism.

Abstract
Bile acids have been implicated in biliary tract carcinogenesis, in part, by activating the epidermal growth factor receptor (EGFR). Overexpression of Mcl-1, a potent antiapoptotic protein of the Bcl-2 family, has also been reported in cholangiocarcinomas. Because receptor tyrosine kinases like EGFR may modulate antiapoptotic protein expression, we examined the hypothesis that bile acids modulate Mcl-1 expression levels via EGFR. Deoxycholate increased cellular Mcl-1 protein in a concentration-dependent manner. The deoxycholate-mediated increase of cellular Mcl-1 protein was blocked equally by EGFR tyrosine kinase inhibitors or an EGFR-neutralizing antibody. Although inhibition of mitogen-activated protein kinases did not attenuate the deoxycholate-associated increase in Mcl-1 protein, the Raf-1 inhibitor, BAY 37-9751, effectively blocked the cellular increase of this protein. Neither Mcl-1 transcriptional activity nor its mRNA stability was altered by deoxycholate treatment. However, Mcl-1 protein stability was increased by bile acid treatment, an effect duplicated by proteasome inhibition. Deoxycholate prolongation of Mcl-1 turnover was blocked by either EGFR inhibitors or the Raf-1 inhibitor. Whereas the deoxycholate-induced increase in Mcl-1 reduced Fas-mediated apoptosis, the Raf-1 inhibitor potentiated Fas apoptosis. Our results demonstrate that bile acids block Mcl-1 protein degradation via activation of an EGFR/Raf-1 cascade resulting in its cellular accumulation. Raf-1 inhibitors block this increase of Mcl-1 and render the cells more susceptible to apoptosis, a potential therapeutic strategy for cholangiocarcinomas.
AuthorsJung-Hwan Yoon, Nathan W Werneburg, Hajime Higuchi, Ali E Canbay, Scott H Kaufmann, Cahit Akgul, Steven W Edwards, Gregory J Gores
JournalCancer research (Cancer Res) Vol. 62 Issue 22 Pg. 6500-5 (Nov 15 2002) ISSN: 0008-5472 [Print] United States
PMID12438243 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Neoplasm Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Messenger
  • Deoxycholic Acid
  • ErbB Receptors
  • Proto-Oncogene Proteins c-raf
Topics
  • Apoptosis (drug effects, physiology)
  • Cholangiocarcinoma (metabolism)
  • Deoxycholic Acid (pharmacology)
  • ErbB Receptors (antagonists & inhibitors, physiology)
  • Humans
  • MAP Kinase Signaling System (drug effects, physiology)
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Neoplasm Proteins (antagonists & inhibitors, biosynthesis, genetics, metabolism)
  • Proto-Oncogene Proteins c-bcl-2
  • Proto-Oncogene Proteins c-raf (antagonists & inhibitors, physiology)
  • RNA, Messenger (biosynthesis, genetics)
  • Transcription, Genetic (drug effects)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: